In line with our mission statement, "To help people affected by carcinoid and other rare cancers through funding research for new treatments, providing financial support for patients and their families, and promoting awareness and education, "The Lois Merrill Foundation provides funding for the following grant:
Medical Assistance Grant
Provides carcinoid and other rare cancer patients with assistance in the payment of medical expenses. This grant is based on financial need and the average awards is less than $2,000 per applicant. Application instructions are included in each document.
It is important that each application is filled out completely prior to being submitted for review. Incomplete applications may be returned and their processing delayed.
Grant Submission & Review Schedule For 2020:
Rare Cancer Requests must be received by March 28
Determinations will be made by April 3
Grants Accepted by The Lois Merrill Foundation through April 17th
FINAL APPLICATION DEADLINE: May 1st, 2020 (All applications due by this date)
Application review - May 2020
Notification of awards - June 2020
Rare Cancer Qualification: For the purpose of awarding Medical Assistance Grants, rare cancer will be defined as any cancer that has been classified as a rare cancer by U.S. governmental granting agencies. Examples include but are not limited to the National Institute of Health (NIH), the National Cancer Institute (NCI) or the American Cancer Society (ACS). Preference will be given to patients suffering from carcinoid cancer, as that is our primary focus.
Does my cancer qualify as rare?
Provide us with a detailed description of your cancer type between by April 15
The LMF will provide you with a determination by: May 15
Qualifying applications are due by: June 1
2021 Application will be available in January 2021
A non-profit organization focused on encouraging and supporting research and education of carcinoid and related neuroendocrine cancers.
A non-profit organization with a mission to discover cures for carcinoid cancer, pancreatic neuroendocrine cancer, and related neuroendocrine cancers. NTRF also works to eliminate the suffering of patients, families, and caregivers affected by neuroendocrine cancers.